Nvidia's Best Day Since April 2025, Cybersecurity Stocks Go Vertical: Stock Market Today
Nvidia surged 9% and cybersecurity names exploded higher, yet 10 of 11 S&P 500 sectors fell as yields firmed before Jackson Hole.
Read original at benzingaStocks · News reference
Moderna Doses First US Participant In Its Phase 1 Study Of mRNA-4200, Tumor-Targeted Cancer Antigen Therapy Candidate, For Advanced Or Metastatic Solid Tumors
Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced or metastatic
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 16, 2026, 11:03 AM
- Checked
- Jul 16, 2026, 11:03 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Moderna Borrows $2 Billion To Expand Oncology Business
Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth and strategically manage debt.
Read original at benzingaModerna shares are trading lower after the company announced a proposed $2 billion offering of convertible senior notes.
Read original at benzingaModerna Announces Proposed $2B Offering Of Zero-Coupon Convertible Senior Notes Due 2032, Plus $300M Purchase Option
Read original at benzinga